Seroprevalence and Risk Factors for Herpes Simplex Virus Infection in a Population of HIV-Infected Patients in Canada
May 18, 2009
The researchers in the current study set out to determine the seroprevalence of herpes simplex virus (HSV) in a population of HIV-positive patients in Canada. The study participants were HIV patients attending five infectious-disease clinics for follow-up care.
Noting that "a significant proportion of HIV-infected subjects attending five infectious-disease clinics in Canada are co-infected with HSV," the authors concluded that "routine type-specific HSV-2 testing should be introduced to direct education regarding symptoms, signs, and transmission reduction of genital herpes, and perhaps ultimately of HIV-1. Knowledge of HSV serostatus would also provide an opportunity to consider antiviral therapy."
Sexually Transmitted Diseases
03.09.2009; Vol. 36; No. 3: P. 165-169; Barbara Romanowski, MD, FRCPC, FACP, and others
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.